Compounds > resiquimod
Page last updated: 2024-09-04

resiquimod and Eczema, Atopic

resiquimod has been researched along with Eczema, Atopic in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amakawa, R; Amuro, H; Fukuhara, S; Ito, T; Katashiba, Y; Ogata, M; Sugimoto, H; Tanijiri, T; Torii, Y; Yokoi, T1
Anton, K; Frotscher, B; Worm, M1
Hengge, UR; Meykadeh, N1

Other Studies

3 other study(ies) available for resiquimod and Eczema, Atopic

ArticleYear
Imidazoquinoline acts as immune adjuvant for functional alteration of thymic stromal lymphopoietin-mediated allergic T cell response.
    Journal of immunology (Baltimore, Md. : 1950), 2008, Oct-15, Volume: 181, Issue:8

    Topics: Adjuvants, Immunologic; Cells, Cultured; Cytokines; Dendritic Cells; Dermatitis, Atopic; Gene Expression Regulation; Humans; Imidazoles; Inflammation; Interferon-gamma; Interleukin-10; Interleukin-12; OX40 Ligand; Steroids; Th2 Cells; Thymic Stromal Lymphopoietin

2008
Inhibition of IgE production by the imidazoquinoline resiquimod in nonallergic and allergic donors.
    The Journal of investigative dermatology, 2002, Volume: 119, Issue:5

    Topics: Adult; Antibodies, Monoclonal; B-Lymphocytes; CD40 Antigens; Cell Division; Dermatitis, Atopic; Down-Regulation; Humans; Imidazoles; Immunoglobulin E; In Vitro Techniques; Interferon-gamma; Interleukin-12; Interleukin-4; Receptors, IgE; Rhinitis, Allergic, Seasonal; Up-Regulation

2002
[Topical immunomodulators in dermatology].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2003, Volume: 54, Issue:7

    Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aged; Aged, 80 and over; Aminoquinolines; Asthma; Autoimmune Diseases; Bowen's Disease; Child; Cyclopropanes; Dermatitis, Atopic; Dinitrochlorobenzene; Female; Follow-Up Studies; Herpes Simplex; Humans; Imidazoles; Imiquimod; Immunity, Cellular; Immunocompromised Host; Immunoglobulin A; Immunosuppressive Agents; Lichen Sclerosus et Atrophicus; Male; Molluscum Contagiosum; Papillomavirus Infections; Precancerous Conditions; Skin Diseases; Skin Diseases, Viral; Skin Neoplasms; Tacrolimus; Time Factors; Warts

2003